RNPC3 and systemic sclerosis: Approximately 10% of patients with “seronegative” SSc have been found to have specific antibodies, including anti-elF2B, anti-RuvBL1/2 complex, anti-RNP U11/U12, anti-RNPC3 and anti-BICD2.